Skip to content

Drug interactions

Indinavir + Linagliptin

Severity: Minor

Indinavir and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Indinavir inhibits CYP3A4 and may raise linagliptin levels, though the effect is expected to be modest given linagliptin's limited metabolism. Protease inhibitors may also cause insulin resistance and hyperglycemia, working against glycemic control.

What this interaction means in plain words

Indinavir and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

CYP3A4/P-gp inhibition by indinavir may increase linagliptin exposure, while protease inhibitor-related insulin resistance antagonizes glucose lowering.

What to do

No linagliptin dose change is needed; monitor blood glucose and HbA1c during indinavir therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indinavir and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Indinavir with Linagliptin?

MediHelp rates the interaction as minor. Indinavir and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Indinavir inhibits CYP3A4 and may raise linagliptin levels, though the effect is expected to be modest given linagliptin's limited metabolism. Protease inhibitors may also cause insulin resistance and hyperglycemia, working against glycemic control.

How serious is the interaction between Indinavir and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No linagliptin dose change is needed; monitor blood glucose and HbA1c during indinavir therapy.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in